The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Chauss�e de la Hulpe 166
Brussels, B-1170 Belgium
The International Diabetes Federation (IDF) is a federation dedicated to working with its member associations to enhance the lives of people affected by diabetes mellitus, a condition characterized by impaired carbohydrate, fat, and protein metabolism due to deficient production or action of insulin. In type I diabetes, little or no insulin is produced, resulting in an abrupt onset of such symptoms as abnormal thirst, excessive urination, extreme fatigue, constant hunger, blurred vision, irritability, and additional symptoms and findings. This condition, which usually becomes apparent during childhood or adolescence, requires administration of insulin. Type II diabetes, is characterized by insufficient production of insulin, causing a gradual onset of fatigue, blurred vision, unusual thirst, frequent urination, and other abnormalities. This condition typically becomes apparent during adulthood and may often be controlled through diet, routine exercise, and oral medications. The International Diabetes Federation was established in 1950 and has evolved into an umbrella organization consisting of 185 national associations in 145 countries.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.